Maria Carrillo
Maria Carrillo is the Chief Science Officer of the Alzheimer's Association, where she plays a pivotal role in advancing research and awareness about Alzheimer’s disease. Her expert insights on biomarkers, particularly p-tau217, are instrumental in understanding the diagnosis and progression of Alzheimer’s, contributing to the development of innovative testing methods that aim to improve early detection and treatment.
Not in the pool (under ¢1).
Recent news mentions
María Carrillo is affiliated with Juntos por el Perú and associated with Radio la Voz de Puquio.
Franja electoral | Denuncian que partidos destinaron fondos públicos a medios de comunicación vinculados a sus militantes | Elecciones 2026 | últimas | POLITICA
Peru· 2026-02-09
Maria Carrillo spoke in support of the Riverside Poly players and condemned parents enabling male children to play in girls' sports.
California volleyball team faces more forfeits amid trans athlete controversy
United States· 2025-08-24
Dr. Maria Carrillo, chief science officer and medical affairs lead at the Alzheimer’s Association, said in a statement Friday that she is hopeful it will be easier for more individuals to receive an accurate diagnosis earlier.
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the USUnited States· 2025-05-18
Dr. Maria Carrillo is the chief science officer of the Alzheimer’s Association and has commented on the effectiveness of p-tau217 as a biomarker for Alzheimer’s.
‘Amazing’ reduction in Alzheimer’s risk verified by blood markers, study saysUnited States· 2025-04-08
